ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Phase 2

MK-677 (Ibutamoren)

MK-677 (Ibutamoren)

Also known as: MK-677, Ibutamoren, MK-0677, L-163, 191, Nutrobal

Overview

Key Facts

Primary Goal: Research and therapeutic applications of MK-677 (Ibutamoren)

Mimics ghrelin by agonizing the GHS-R1a receptor to stimulate pituitary GH release. Produces sustained GH elevation by activating both hypothalamic and pituitary ghrelin receptors.

Dosing Information

Half-Life

24 hours

Typical Dose

10–25 mg

Frequency

once daily

Cycle Length

8-16 weeks (some research protocols extend longer)

Administration Routes:
oral

Benefits

  • Oral administration — no injections required
  • Sustained 24-hour GH and IGF-1 elevation
  • Significant improvement in sleep quality
  • Increased lean body mass in clinical studies
  • Improved bone mineral density with long-term use
  • Convenient once-daily dosing

Side Effects

Increased appetite and hungermild
Water retention and bloatingmild
Elevated fasting blood glucose and insulin resistancemild
Lethargy and fatigue, especially initiallymild
Numbness or tingling in extremitiesmild

Mechanism of Action

1

Mimics ghrelin by agonizing the GHS-R1a receptor to stimulate pituitary GH release

2

Produces sustained GH elevation by activating both hypothalamic and pituitary ghrelin receptors

3

Increases appetite through hypothalamic NPY/AgRP signaling pathway

4

Does not suppress natural GH pulsatility or HPTA function

Contraindications

Do not use this peptide if any of the following apply:

  • Insulin resistance or type 2 diabetes
  • Active malignancy
  • Congestive heart failure (fluid retention risk)
  • Pregnancy or breastfeeding

Storage & Reconstitution

Unreconstituted (Powder)

Temperature15–25°C (59–77°F)
DurationUp to 3 months

Reconstituted (Mixed)

Temperature15–25°C (59–77°F)
Duration2-4 weeks

Research Summary

Phase 2

MK-677 has been studied in multiple Phase II trials for muscle wasting, osteoporosis, and GH deficiency. A landmark 2-year study in elderly adults demonstrated sustained increases in GH and IGF-1 without tachyphylaxis, along with improved lean mass. However, concerns about insulin resistance and glucose metabolism have prevented FDA approval to date.

Frequently Asked Questions

Common questions about MK-677 (Ibutamoren)

UK-Specific Information

Exclusive data points and guidance for UK residents using MK-677 (Ibutamoren)

UK Lab Testing

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With

Share on TikTok

Generate a trackable link to share this peptide information on TikTok